Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
Total Revenue |
1 |
1 |
1 |
1 |
Cost of Revenue |
– |
– |
– |
– |
|
Gross Profit |
1 |
1 |
1 |
1 |
|
|
Operating Expenses |
|
Research Development |
136 |
29 |
21 |
21 |
|
Selling General and Administrative |
347 |
265 |
236 |
3,276 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
Operating Income or Loss |
(482) |
(292) |
(256) |
(3,296) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
79 |
(128) |
(3) |
(34) |
|
Earnings Before Interest And Taxes |
(402) |
(421) |
(259) |
(3,330) |
|
Interest Expense |
135 |
6 |
6 |
6 |
|
Income Before Tax |
(537) |
(427) |
(265) |
(3,337) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
88 |
41 |
34 |
37 |
|
|
|
Net Income From Continuing Ops |
(449) |
(386) |
(231) |
(3,300) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
Net Income |
(449) |
(386) |
(231) |
(3,300) |
Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
Net Income Applicable To Common Shares |
(449) |
(386) |
(231) |
(3,300) |
|